The effect of combined therapy using rosuvastatin and dihydroarteminin in a pulmonary malaria mouse model.
C. BATISTA (Rio de janeiro, Brazil), H. D’Anunciação De Oliveira (Rio de janeiro, Brazil), A. Garcia-Darze (Rio de janeiro, Brazil), M. Lima (Rio de janeiro, Brazil), É. Amorim (Rio de janeiro, Brazil), A. Silva (Rio de janeiro, Brazil), H. Caire Castro-Faria-Neto (Rio de janeiro, Brazil), T. Maron-Gutierrez (Rio de janeiro, Brazil)
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Disease area: Respiratory critical care
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. BATISTA (Rio de janeiro, Brazil), H. D’Anunciação De Oliveira (Rio de janeiro, Brazil), A. Garcia-Darze (Rio de janeiro, Brazil), M. Lima (Rio de janeiro, Brazil), É. Amorim (Rio de janeiro, Brazil), A. Silva (Rio de janeiro, Brazil), H. Caire Castro-Faria-Neto (Rio de janeiro, Brazil), T. Maron-Gutierrez (Rio de janeiro, Brazil). The effect of combined therapy using rosuvastatin and dihydroarteminin in a pulmonary malaria mouse model.. 4290
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: